Prophylaxis of Graft-versus-host Disease With Anti-CD25 Antibody in Patients Underwent HSCT
Clinical trial NCT06334367 · UNKNOWN
Trial details
- NCT number
- NCT06334367
- Sponsor
- Wang Xin
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-26
- Primary completion
- 2026-03-26
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.